acute pancreatitis
Conditions
Interventions
Experimental group:After the operation of pancreatitis, the experimental group received somatostatin for injection (Sitanin, manufacturer name: Merck Serono SAAubonne Branch
implementation standard JX20140241 approval number: H20140873), and the administration method was 6mg+50ml. Microbial infusion of saline vein (250 micrograms per hour) once a d
control group :The 50ml saline vein was pumped once a day for 5 days
Sponsors
West China Hospital, Sichuan University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. patients who meet the diagnostic criteria for acute pancreatitis; 2. in our hospital for pancreatic necrosis tissue removal.
Exclusion criteria
Exclusion criteria: Patients with acute pancreatitis who have not undergone surgical intervention or who have only puncture drainage. At the time of follow-up, the subjects were not successfully contacted three times on different dates, and the subject was considered to be lost to follow-up.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| mortality rate;Bleeding rate;New organ failure;Reoperation rate;Pancreatic fistula incidence; | — |
Secondary
| Measure | Time frame |
|---|---|
| Length of hospital stay;Medical expenses;ICU length of hospital stay; | — |
Countries
China
Contacts
Public ContactWeiming Hu
West China Hospital, Sichuan University
Outcome results
None listed